Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release
Dongbiao Shen1, Xiang Wang, Xinran Li
1Department of Molecular, Cellular and Developmental Biology, University of Michigan, 3089 Natural Science Building (Kraus), 830 North University, Ann Arbor 48109, USA.
Abstract:
Lysosomal lipid accumulation, defects in membrane trafficking and altered Ca(2+) homoeostasis are common features in many lysosomal storage diseases. Mucolipin transient receptor potential channel 1 (TRPML1) is the principle Ca(2+) channel in the lysosome. Here we show that TRPML1-mediated lysosomal Ca(2+) release, measured using a genetically encoded Ca(2+) indicator (GCaMP3) attached directly to TRPML1 and elicited by a potent membrane-permeable synthetic agonist, is dramatically reduced in Niemann-Pick (NP) disease cells. Sphingomyelins (SMs) are plasma membrane lipids that undergo sphingomyelinase (SMase)-mediated hydrolysis in the lysosomes of normal cells, but accumulate distinctively in lysosomes of NP cells. Patch-clamp analyses revealed that TRPML1 channel activity is inhibited by SMs, but potentiated by SMases. In NP-type C cells, increasing TRPML1's expression or activity was sufficient to correct the trafficking defects and reduce lysosome storage and cholesterol accumulation. We propose that abnormal accumulation of luminal lipids causes secondary lysosome storage by blocking TRPML1- and Ca(2+)-dependent lysosomal trafficking.
Insights
Niemann-Pick disease cells show reduced lysosomal calcium release due to lipid buildup blocking the TRPML1 channel. Restoring TRPML1 function corrects cellular defects, offering a therapeutic target for lysosomal storage diseases.
Area of Science:
- Cell Biology
- Molecular Medicine
- Genetics
Background:
- Lysosomal storage diseases share common features like lipid accumulation, impaired membrane trafficking, and disrupted calcium (Ca2+) homeostasis.
- The mucolipin transient receptor potential channel 1 (TRPML1) is the primary Ca2+ channel within lysosomes.
Purpose of the Study:
- To investigate the role of TRPML1 channel function in Niemann-Pick (NP) disease.
- To explore the impact of sphingomyelin (SM) accumulation on TRPML1 activity.
- To assess the therapeutic potential of modulating TRPML1 in NP disease.
Main Methods:
- Utilized a genetically encoded Ca2+ indicator (GCaMP3) attached to TRPML1 to measure lysosomal Ca2+ release.
- Employed patch-clamp analyses to assess TRPML1 channel activity.
- Investigated NP-type C cells with varying levels of TRPML1 expression and activity.
Main Results:
- TRPML1-mediated lysosomal Ca2+ release was significantly reduced in NP disease cells.
- Accumulated sphingomyelins (SMs) in NP cells inhibited TRPML1 channel activity, while sphingomyelinases (SMases) potentiated it.
- Enhancing TRPML1 expression or activity in NP-type C cells corrected trafficking defects and reduced lysosomal storage and cholesterol accumulation.
Conclusions:
- Abnormal lysosomal lipid accumulation, particularly sphingomyelins, impairs TRPML1 channel function.
- This impairment leads to secondary lysosomal storage by blocking TRPML1- and Ca2+-dependent lysosomal trafficking.
- Modulating TRPML1 offers a potential therapeutic strategy for Niemann-Pick disease and related lysosomal storage disorders.
Related Concept Videos
Lysosomal Hydrolases
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Lipid-Lowering Drugs: Statins and Miscellaneous Agents


